Vital Signsby BridgeheadAll voices

01  Voice · Clinician · Respiratory (asthma/COPD)

Darush Attar-Zadeh: no photograph is held, so the Primary Care Respiratory Society (PCRS) monogram is shown instead.
Clinician

Darush Attar-Zadeh

Executive Chair, Primary Care Respiratory Society; Clinical Fellow Respiratory Pharmacist, North West London Integrated Care Board, Primary Care Respiratory Society (PCRS)

Press coverage by month · bar height shows relative volume
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
Also cited

Quoted in the press on 1 topic since 2 Oct 2025

Where their coverage sitsLower 50%

Voices are sorted into four fixed groups by how much press coverage they have had across all topics, from the top 5% down to the lower half. The lit step is Darush Attar-Zadeh’s group.

02  Quoted on · 2 of 29 topics

Open the topic

Darush Attar-Zadeh: key facts

Kind of voice
Clinician
Role
Executive Chair, Primary Care Respiratory Society; Clinical Fellow Respiratory Pharmacist, North West London Integrated Care Board
Organisation
Primary Care Respiratory Society (PCRS)
Quoted on
Respiratory (asthma/COPD), Public health & prevention
Press coverage
Also cited
Most recently quoted
16 Sept 2026
First quoted
2 Oct 2025

03  Profile

Who Darush Attar-Zadeh is

Darush Attar-Zadeh is a pharmacist and independent prescriber. He is a clinical fellow respiratory lead pharmacist for North West London Integrated Care Board (NWL ICB) and a lead for NHS RightBreathe.

He is also Executive Chair of the Primary Care Respiratory Society (PCRS) and a member of Asthma + Lung UK's Council of Healthcare Professionals. He co-chairs the Taskforce for Lung Health's Medicines Optimisation Working Group. He is quoted in the pharmacy press on asthma and inhaler use, including salbutamol overuse and inhaled corticosteroids in pregnancy.

He also comments on smoking cessation, vaping and nicotine pouches. His stated aims include reducing health inequalities caused by tobacco and by respiratory conditions, and he teaches in deprived areas across the UK.

Notable achievements

  1. 01

    Awarded PCPA GP Pharmacist runner up in 2019 Source ↗

  2. 02

    As respiratory lead pharmacist (Barnet CCG & RightBreathe), led a medicines management service that won the pharmacist award in respiratory services in 2016 Source ↗

  3. 03

    Is Executive Chair of the Primary Care Respiratory Society Source ↗

  4. 04

    Helped develop NHS RightBreathe. His team was highly commended at the HSJ awards in 2017 and 2024, according to the Life Science Access Academy. Source ↗

  5. 05

    Was asked to help review the National Training Standards for Smoking Cessation Source ↗

04  The signal · where Darush Attar-Zadeh sits on respiratory (asthma/copd)

Leading

One of the voices most often quoted in the press on respiratory (asthma/copd).

Placed by press coverage on this topic only, not across all topics.

  1. Dr Andy Whittamore portraitDr Andy WhittamoreClinicianClinical Lead (and practising GP), Asthma + Lung UKLeading
  2. Dr Amina Al-YassinClinicianClinical Lead for Children and Young People's Services at Brent Integrated Care PartnershipLeading
  3. Are HolmAcademicHead of the Department of Respiratory Medicine at Oslo University Hospital RikshospitaletLeading
  4. Dr Anastasia Chalkidou portraitDr Anastasia ChalkidouRegulatorProgramme Director, Guidance Delivery – HealthTech, National Institute for Health and Care Excellence (NICE)Leading
  5. Dr. Goncagul AldanAcademicLecturer and nurse, Hacettepe University Faculty of NursingLeading
  6. Darush Attar-ZadehClinicianExecutive Chair, Primary Care Respiratory Society; Clinical Fellow Respiratory Pharmacist, North West London Integrated Care Board, Primary Care Respiratory Society (PCRS)Leading
  7. Joseph CarterSector leaderHead of Scotland (Devolved Nations), Asthma + Lung UKLeading
  8. Prof Sanjay AgrawalClinicianRoyal College of Physicians special advisor and consultant in respiratory and intensive careLeading

Showing the leading voices and those placed around Darush Attar-Zadeh · See every voice on the topic →

05  On the record · press

What Darush Attar-Zadeh has said

By outlet · bar length shows relative volume
  • pharmaceutical-journal.com
  • nursinginpractice.com

Where Darush Attar-Zadeh has been quoted

  1. Large areas of England do not commission enough childhood asthma testspharmaceutical-journal.com · 16 Sept 2026
  2. Hierarchy of harm: nicotine alternatives in a post-tobacco eranursinginpractice.com · 8 Jun 2026
  3. Tezepelumab may reduce need for oral corticosteroids in severe asthmapharmaceutical-journal.com · 1 Jun 2026
  4. NICE approves add-on treatment for uncontrolled COPDpharmaceutical-journal.com · 28 May 2026
  5. NICE recommends treatment that could help 30,000 people with COPDpharmaceutical-journal.com · 26 Jan 2026
  6. NICE recommends apps for use in asthma managementpharmaceutical-journal.com · 7 Jan 2026
  7. Monthly injection for severe asthma cuts need for daily oral corticosteroidspharmaceutical-journal.com · 28 Nov 2025
  8. Combination inhaler therapy cuts asthma attacks in children by almost halfpharmaceutical-journal.com · 2 Oct 2025
How we found the articles that name Darush Attar-Zadeh: we searched news for these terms, by topic. Terms for 2 topics

Respiratory (asthma/COPD)

  • asthma
  • COPD
  • respiratory disease
  • lung cancer screening
  • pulmonary

Also searched with “asthma” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Respiratory (asthma/COPD)

Public health & prevention

  • public health
  • preventative healthcare
  • prevention agenda
  • health prevention
  • obesity strategy
  • childhood obesity
  • smoking cessation
  • smoke-free

Also searched with “public health” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Public health & prevention

Verbatim

“As a pharmacist working in children and young people's asthma, I am deeply concerned by these findings, particularly following NICE's recommendations in November 2024.”
clinical fellow respiratory pharmacist with NHS West and North London integrated care board · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 16 Sept 2026 · Read the article
“'Nicotine is addictive,' he said, but it is the tar produced by combustion – with '69 cancer causing components' – that kills.”
Clinical fellow pharmacist · Public health & prevention · nursinginpractice.com · 8 Jun 2026 · Read the article
“This is a double-blinded study, which adds another huge layer of evidence to support the previous WAYFINDER finding. What's also pleasing to see is that in the cohort of patients that were on tezepelumab, it not only reduced the annualised asthma exacerbation rates but also resulted in clinically meaningful improvements in lung function and asthma symptom control, despite a reduction in the daily maintenance oral corticosteroids.”
honorary clinical fellow respiratory pharmacist at North West London Integrated Care Board · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 1 Jun 2026 · Read the article
“publication of the guidance is "a fabulous milestone to reduce exacerbation frequency, and it will benefit the person living with COPD significantly"”
honorary clinical fellow respiratory pharmacist at North West London Integrated Care Board · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 28 May 2026 · Read the article
“The approval of dupilumab by NICE is very welcome news for people living with COPD. Dupilumab was approved for use in severe asthma in 2021, and it is encouraging to now see strong evidence demonstrating its effectiveness in a specific cohort of COPD patients.”
honorary clinical fellow respiratory pharmacist at North West London Integrated Care Board · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 26 Jan 2026 · Read the article
“AI-enabled digital tools have the potential to enhance asthma care by supporting self-management, improving medicines use and enabling earlier intervention. Tools under NICE review show promise in improving asthma control and reducing hospital visits.”
respiratory pharmacist, co-chair of the London-based Children and Young People Pharmacy Asthma Group and co-chair of the Taskforce for Lung Health Medicines Optimisation Working Group · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 7 Jan 2026 · Read the article
“Severe asthma affects only a small proportion of the patients I see, but for those who rely on daily OCS, the burden is substantial. I would love to see a day when routine OCS use is a thing of the past, given the well-known side effects even at low doses.”
clinical fellow respiratory pharmacist at North West London Integrated Care Board · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 28 Nov 2025 · Read the article
“I'm happy to see this study as we can't assume whatever is safe and effective in adults is going to be safe in children. We've known for many years that asthma is a condition of inflammation and needs to be treated with an anti-inflammatory inhaler, so it doesn't come as any real surprise that asthma attacks are reduced by 45%.”
Clinical fellow respiratory pharmacist and executive chair of the Primary Care Respiratory Society · Respiratory (asthma/COPD) · pharmaceutical-journal.com · 2 Oct 2025 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

06  Sources

References for this biography

  1. Darush Attar-Zadeh - PCRS. Describes him as a Clinical Fellow Pharmacist. Also covers his NHS RightBreathe lead role, the 2019 PCPA award, PCRS committee roles and Taskforce co-chair role.
  2. On Demand webinar: Is the next generation at risk? Tackling Youth Smoking and Vaping - PCRS. Describes him as PCRS Executive Chair and shows his work on youth smoking and vaping.
  3. On Demand ARC webinar: Inhaler technique optimisation and adherence through patient partnership - PCRS. Covers the 2016 respiratory services pharmacist award, the 2019 award, and his focus on tobacco dependency and AsthmaRightCare.
  4. 'Let's make a societal shift towards ending smoking for good' - The Pharmacist. Shows him as a clinical fellow pharmacist, member of Asthma + Lung UK's Council of Healthcare Professionals and PCRS executive chair. Also shows his published commentary on smoking cessation funding.
  5. Pharmacist and dentist-led smoking cessation clinic led to 20% quit rate - The Pharmaceutical Journal. Quoted as honorary clinical fellow respiratory pharmacist at NWL ICB, on smoking cessation.
  6. Inhaled corticosteroids not linked to increased risks during pregnancy, study suggests - The Pharmaceutical Journal. Quoted on asthma control and inhaler use in pregnancy.
  7. Coroner calls for greater recognition of clinical significance of 'excessive' salbutamol inhaler use - The Pharmaceutical Journal. Quoted on frequent salbutamol requests as a marker of poor asthma control that should prompt a clinical review.
  8. Bupropion to be made available in the UK again from December 2023 - The Pharmaceutical Journal. Quoted as co-chair of the Taskforce for Lung Health medicines optimisation working group.
  9. Everything you need to know about oral nicotine pouches - The Pharmaceutical Journal. Quoted on nicotine pouches.
  10. Hierarchy of harm: nicotine alternatives in a post-tobacco era - Nursing in Practice. Described as a clinical fellow pharmacist speaking at a Nursing in Practice 365 event in London on 30 April on smoking cessation, vaping and nicotine replacement.
  11. Darush Attar-Zadeh - IPCRG. Lists him as PCRS Executive Chair, Pharmacist and Independent Prescriber, and Clinical Fellow Respiratory Lead Pharmacist at NWL / NHS RightBreathe.
  12. PCN Respiratory Study Day 2025 - speaker profile. Says he supports 45 PCNs across NWL on the sustainability agenda and helped review the National Training Standards for Smoking Cessation.
  13. Darush Attar-Zadeh - Life Science Access Academy. Says he helped develop NHS RightBreathe, that his team was highly commended at the HSJ awards in 2017 and 2024, and that he has written over 40 peer-reviewed articles. Also gives his BPharm and independent prescriber qualification.
  14. darush attar-zadeh (@DarushAttar) on X. The X profile describes him as a respiratory pharmacist with the NW London CYP Asthma Network and RightBreathe, and a smoking cessation national trainer. This matches his other profiles.
  15. Darush Attar-Zadeh - LinkedIn. LinkedIn profile in his name. Its content matches his smoking cessation and London Clinical Senate work.

07  Contact & links

LinkedIn
linkedin.com/in/darush-attar-zadeh-325a706
X
x.com/darushattarpublished here ↗
Staff page
pcrs-uk.org/committee-member/25782

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.

Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 3 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.